LIGAND PHARMACEUTICALS INC — Director's Dealing 2018

Jun 21, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2018-06-19

Reporting Person: Patel Sunil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-19	Common Stock	A	493	$0.00	Acquired	39806	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-19	Non-Qualified Stock Option (right to buy)	$76.77	A	2474	Acquired	2028-06-18	Common Stock (2474)	Direct

Footnotes

F1: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 19, 2018. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.